The National Pharmaceutical Pricing Authority (NPPA) on April 25, 2024, issued a notification regarding the fixation of the Retail price of each film-coated tablet containing: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 1000mg (as Extended release).
The following has been stated namely: -
• It has fixed the rate at Rs. 16.43/- for the Composition of Each film-coated tablet containing: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 1000mg (as Extended release).
• It has fixed the rate at Rs. 9.27/- for the Composition of Each film-coated tablet containing: Metformin (1000mg) (as Extended release) + Glimepiride(1mg).
• It has fixed the rate at Rs. 11.21/- for the Composition of Each film-coated tablet containing: Metformin (1000mg) (as Extended release) + Glimepiride(2mg).
• It has fixed the rate at Rs. 11.79/- for the Composition of Each film-coated tablet containing: Metformin (1000mg) (as Extended release) + Dapagliflozin(10mg).
• It has fixed the rate at Rs. 12.15/- for the Composition of Each film-coated tablet containing: Dapagliflozin 10mg.
[Notification no. - 9(3940)/2024/DP/NPPA/Div.II]
